Latest Listings And Ipos News

Pacific Edge Limited (ASX – PEB) has announced a securities purchase plan (SPP) aiming to raise up to NZD 5 million, contingent on shareholder approval of a prior NZD 16 million placement. The move is designed to bolster working capital amid ongoing growth initiatives.

Gold Road Resources has agreed to a $3.40 per share acquisition by Gold Fields, combining fixed and variable cash components tied to Northern Star shares. Meanwhile, Gruyere mine production remains steady, with costs edging higher and strong cash flow underpinning the company’s financial position.

Complii FinTech Solutions reported an 11.8% increase in customer receipts for Q4 FY25, alongside a 4.3% quarterly rise in annual recurring revenue, underscoring its expanding footprint in capital raising and compliance software.

betr Entertainment has unveiled an all-scrip takeover bid for PointsBet, offering shareholders 3.81 betr shares per PointsBet share, valuing the offer above a competing cash bid and promising significant cost synergies.

The ASX has published its latest list of entities suspended from trading for over three months, outlining key deadlines for report lodgement and trading resumption plans. Failure to meet these deadlines risks removal from the official list.

Rapid Critical Metals has completed its capital consolidation and placement, reshaping its issued capital structure with shareholder approval.

Clean Seas Seafood’s takeover by Yumbah Aquaculture has been formally approved and registered, marking a key milestone in the seafood sector consolidation. Share trading is suspended as shareholders prepare for compensation.

Canyon Resources has begun construction of the Inland Rail Facility and upgraded haulage road in Cameroon, key steps toward first bauxite production and shipment in 2026.

Imugene Limited has launched a $37.5 million equity raising through a Placement and Share Purchase Plan, offering new shares and options to fund its pivotal azer-cel clinical program. The raise includes attaching and piggyback options, subject to shareholder approval, aiming to bolster the company’s immuno-oncology pipeline.

Imugene Limited has completed a $22.5 million institutional placement and launched a $15 million Share Purchase Plan, both featuring attaching options, to fund its azer-cel clinical program through a pivotal trial in 2026.

Lumos Diagnostics has inked a landmark six-year exclusive distribution agreement with PHASE Scientific for its FebriDx® rapid diagnostic test in the US, potentially unlocking nearly half a billion Australian dollars in revenue contingent on FDA approval.

The Federal Court has approved Yumbah Aquaculture’s acquisition of Clean Seas Seafood, setting the stage for a significant consolidation in Australia’s seafood farming sector. Shareholders face a choice between cash or shares as the scheme moves toward implementation.